(Circulation. 1997;95:732-739.)
© 1997 American Heart Association, Inc.
Articles |
the First Department of Internal Medicine, Mie University, Tsu, Japan.
Correspondence to Tetsu Yamakado, MD, First Department of Internal Medicine, Mie University, Edobashi 2-174, Tsu 514, Japan.
Background MCI-154 is a positive inotropic agent that increases the myofilament response to Ca2+. Whether MCI-154 has beneficial effects on left ventricular dysfunction in chronic heart failure is not known. We examined the effects of MCI-154 on left ventricular systolic and diastolic function in pacing-induced heart failure in dogs.
Methods and Results We studied eight anesthetized dogs before and 2 to 4 weeks after rapid right ventricular pacing. Left cineventriculograms with simultaneous left ventricular pressures (tip manometer) were obtained before and during intravenous administration of MCI-154 (1.0 µg·kg-1·min-1 for 15 minutes) in the control and heart-failure states. Left ventricular volume dynamics was derived from frame-by-frame (20-ms) analyses of left ventricular angiograms. In heart failure, left ventricular contractility as assessed by shifts of the end-systolic pressure-volume ratio, evaluated by inferior vena cava occlusion, was improved by MCI-154 (+1.94 mm Hg/mL, P<.05) to an extent similar to that in the control state (+2.47 mm Hg/mL, P<.05). MCI-154 also accelerated left ventricular relaxation, assessed by the time constant of isovolumic pressure decay (T1/2), in both states. The absolute decrease in T1/2 with MCI-154 in heart failure was significantly greater than in the control state (-8.2 versus -3.1 ms, P<.05). In heart failure, MCI-154 shifted the left ventricular diastolic pressure-volume relation clearly downward, suggesting increased diastolic distensibility.
Conclusions MCI-154 improved not only left ventricular systolic function but also diastolic relaxation and distensibility in a chronic heart failure model.
Key Words: calcium heart failure systole diastole inotropic agents
This article has been cited by other articles:
![]() |
S. Takahashi, S. Cho, T. Hara, H. Ureshino, S. Tomiyasu, and K. Sumikawa The Interaction of MCI-154, a Calcium Sensitizer, and Isoflurane on Systemic and Coronary Hemodynamics in Chronically Instrumented Dogs Anesth. Analg., January 1, 2004; 98(1): 30 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishitani, Y. Hattori, F. Sakuraya, H. Onozuka, T. Makino, N. Matsuda, S. Gando, and O. Kemmotsu Effects of Ca2+ Sensitizers on Contraction, [Ca2+]i Transient and Myofilament Ca2+ Sensitivity in Diabetic Rat Myocardium: Potential Usefulness as Inotropic Agents J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 613 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kumamoto, H. Okamoto, M. Watanabe, H. Onozuka, K. Yoneya, I. Nakagawa, S. Chiba, S. Watanabe, T. Mikami, K. Abe, et al. Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154 Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1117 - H1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asai, M. Uechi, N. Sato, W. Shen, T. Meguro, M. A. Mathier, R. P. Shannon, and S. F. Vatner Lack of desensitization and enhanced efficiency of calcium channel promoter in conscious dogs with heart failure Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2219 - H2226. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A Lee and D.G Allen Calcium sensitisers: mechanisms of action and potential usefulness as inotropes Cardiovasc Res, October 1, 1997; 36(1): 10 - 20. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |